News & Perspective

Dec 08, 2010

Dec 08, 2010

Resistant flu cases underline need for new antivirals

(CIDRAP News) – A package of studies and commentary published this week by the Journal of Infectious Diseases points up the ability of influenza viruses to become drug-resistant and continue to spread, highlighting the need for new antivirals.

Oct 13, 2010

Oct 13, 2010

H3N2 a player in early Northern Hemisphere flu season

(CIDRAP News) – More signals suggest the Southern Hemisphere's flu season is winding down, while activity is low at the start of the Northern Hemisphere's flu season, except in China, which is seeing moderate H3N2 circulation.

Oct 06, 2010

Oct 06, 2010

Trial answers some, not all, questions on cell-based flu vaccines

(CIDRAP News) – A new report says that a cell culture derived influenza vaccine and a conventional egg-based vaccine both proved effective in a large international clinical trial, offering support for those who contend that cell-based vaccines should become an important part of flu vaccine supplies in coming years.

Sep 10, 2010

Sep 10, 2010

Japan approves second new flu antiviral this year

(CIDRAP News) – Japan today approved a new long-acting influenza antiviral drug, Inavir (laninamivir), made by Daiichi Sankyo Co. Ltd., marking the second new flu drug licensed there this year.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»